Intensity Therapeutics Announces Reverse Stock Split
PR Newswire —
Intensity's common stock is expected to begin trading on a post-split adjusted basis on February 19, 2026 SHELTON, Conn., Feb. 13, 2026 /PRNewswire/ -- Intensity Therapeutics, Inc. ("Intensity" or "the Company") (Nasdaq: INTS), a late-stage clinical biotechnology company focused on the...